Patents by Inventor Joel H. Waldman

Joel H. Waldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210236430
    Abstract: The present invention relates to a single layer chewable tablet comprising cetirizine, an optical isomer, or a pharmaceutically active salt thereof and at least one polyol. The present invention also relates to a method of alleviating a sign or symptom of allergy by orally administering the same single layer chewable tablet.
    Type: Application
    Filed: January 25, 2021
    Publication date: August 5, 2021
    Inventor: Joel H. Waldman
  • Patent number: 8900632
    Abstract: Coated dosage forms comprising a tablet core, preferably in compressed form, that has a coating over its exterior surface and one or more patterns debossed in the tablet surface are disclosed. Methods for manufacturing such dosage forms are also disclosed.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: December 2, 2014
    Assignee: McNeil-PPC, Inc.
    Inventors: Joel H. Waldman, Anthony S. Bean, Fernanda Franzoi
  • Patent number: D976385
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: January 24, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventor: Joel H. Waldman
  • Patent number: D999826
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: September 26, 2023
    Assignee: Johnson & Johnson Consumer Inc.
    Inventor: Joel H. Waldman